Melissa Thomas, Principal Scientist, Biologics – Protein Technologies, Amgen
Dr. Thomas has more than 12 years’ experience in biologics in the biopharma industry. She has experience in downstream purification and analytical characterization of a wide range of proteins, supporting both large and small molecule therapeutic development. Her work with bispecific modalities has included antibody-based formats as well as alternative scaffolds. Recently, she has led an initiative to couple a standardized biologics relational data model with a LIMS system to define, track and mine protein data from engineering design to final product quality.